IRIS Accounts Production v24.2.0.383 11788302 director 1.2.23 31.1.24 31.1.24 false true false false true false Ordinary 1.00000 Ordinary 1.00000 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh117883022023-01-31117883022024-01-31117883022023-02-012024-01-31117883022022-01-31117883022022-02-012023-01-31117883022023-01-3111788302ns15:EnglandWales2023-02-012024-01-3111788302ns14:PoundSterling2023-02-012024-01-3111788302ns10:Director12023-02-012024-01-3111788302ns10:PrivateLimitedCompanyLtd2023-02-012024-01-3111788302ns10:SmallEntities2023-02-012024-01-3111788302ns10:AuditExempt-NoAccountantsReport2023-02-012024-01-3111788302ns10:SmallCompaniesRegimeForDirectorsReport2023-02-012024-01-3111788302ns10:SmallCompaniesRegimeForAccounts2023-02-012024-01-3111788302ns10:FullAccounts2023-02-012024-01-3111788302ns10:OrdinaryShareClass12023-02-012024-01-3111788302ns10:RegisteredOffice2023-02-012024-01-3111788302ns5:CurrentFinancialInstruments2024-01-3111788302ns5:CurrentFinancialInstruments2023-01-3111788302ns5:Non-currentFinancialInstruments2024-01-3111788302ns5:Non-currentFinancialInstruments2023-01-3111788302ns5:ShareCapital2024-01-3111788302ns5:ShareCapital2023-01-3111788302ns5:RetainedEarningsAccumulatedLosses2024-01-3111788302ns5:RetainedEarningsAccumulatedLosses2023-01-3111788302ns5:FurnitureFittings2023-02-012024-01-3111788302ns5:PlantMachinery2023-01-3111788302ns5:PlantMachinery2023-02-012024-01-3111788302ns5:PlantMachinery2024-01-3111788302ns5:PlantMachinery2023-01-3111788302ns5:CurrentFinancialInstrumentsns5:WithinOneYear2024-01-3111788302ns5:CurrentFinancialInstrumentsns5:WithinOneYear2023-01-3111788302ns5:CurrentFinancialInstruments2023-02-012024-01-3111788302ns5:DeferredTaxation2023-01-3111788302ns5:DeferredTaxation2023-02-012024-01-3111788302ns5:DeferredTaxation2024-01-3111788302ns10:OrdinaryShareClass12024-01-31117883021ns10:Director12023-01-31117883021ns10:Director12022-01-31117883021ns10:Director12023-02-012024-01-31117883021ns10:Director12022-02-012023-01-31117883021ns10:Director12024-01-31117883021ns10:Director12023-01-31
REGISTERED NUMBER: 11788302 (England and Wales)











Unaudited Financial Statements

for the Year Ended 31 January 2024

for

Heart Aesthetics Ltd

Heart Aesthetics Ltd (Registered number: 11788302)






Contents of the Financial Statements
for the Year Ended 31 January 2024




Page

Company Information 1

Balance Sheet 2 to 3

Notes to the Financial Statements 4 to 7


Heart Aesthetics Ltd

Company Information
for the Year Ended 31 January 2024







DIRECTOR: R M Johnson





REGISTERED OFFICE: 2 The Old Grain Store
Moseley's Farm
Fornham all Saints
Bury St Edmunds
Suffolk
IP28 6JY





REGISTERED NUMBER: 11788302 (England and Wales)





ACCOUNTANTS: Knights Lowe Chartered Accountants
Eldo House
Kempson Way
Suffolk Business Park
Bury St Edmunds
Suffolk
IP32 7AR

Heart Aesthetics Ltd (Registered number: 11788302)

Balance Sheet
31 January 2024

2024 2023
Notes £    £    £    £   
FIXED ASSETS
Tangible assets 4 5,022 1,675

CURRENT ASSETS
Stocks 8,530 10,436
Debtors 5 3,888 3,033
Cash at bank 636,440 562,239
648,858 575,708
CREDITORS
Amounts falling due within one year 6 100,426 102,679
NET CURRENT ASSETS 548,432 473,029
TOTAL ASSETS LESS CURRENT LIABILITIES 553,454 474,704

CREDITORS
Amounts falling due after more than one
year

7

(13,334

)

(23,333

)

PROVISIONS FOR LIABILITIES 8 (1,144 ) (403 )
NET ASSETS 538,976 450,968

CAPITAL AND RESERVES
Called up share capital 9 100 100
Retained earnings 538,876 450,868
SHAREHOLDERS' FUNDS 538,976 450,968

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 January 2024.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 January 2024 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges her responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

Heart Aesthetics Ltd (Registered number: 11788302)

Balance Sheet - continued
31 January 2024


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the director and authorised for issue on 16 August 2024 and were signed by:





R M Johnson - Director


Heart Aesthetics Ltd (Registered number: 11788302)

Notes to the Financial Statements
for the Year Ended 31 January 2024

1. STATUTORY INFORMATION

Heart Aesthetics Ltd is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

The presentation currency of the financial statements is the Pound Sterling (£).


2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Income is recognised when treatments are carried out and the company obtains the right to receive consideration. Payments received in advance of treatments are included in creditors.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Fixtures and fittings - 25% on reducing balance

Stocks
Stocks are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items.

Financial instruments
All of the company's financial instruments are considered to be basic. Basic financial instruments are recognised at amortised cost.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Heart Aesthetics Ltd (Registered number: 11788302)

Notes to the Financial Statements - continued
for the Year Ended 31 January 2024

2. ACCOUNTING POLICIES - continued

Hire purchase and leasing commitments
Rentals paid under operating leases are charged to profit or loss on a straight line basis over the period of the lease.

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

Impairment
At each reporting date, goodwill and other fixed assets, including tangible fixed assets and investments but excluding investment properties, are assessed to determine whether there is an indication that the carrying amount of an asset may be more than its recoverable amount and that the asset should be impaired. If there is an indication of possible impairment, the recoverable amount of an asset, which is the higher of its value in use and its net realisable value, is estimated and compared with its carrying amount. If the recoverable amount is lower, the carrying amount of the asset is written down to its estimated recoverable amount and an impairment loss is recognised in the income statement.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 4 (2023 - 4 ) .

4. TANGIBLE FIXED ASSETS
Plant and
machinery
etc
£   
COST
At 1 February 2023 2,605
Additions 4,436
At 31 January 2024 7,041
DEPRECIATION
At 1 February 2023 930
Charge for year 1,089
At 31 January 2024 2,019
NET BOOK VALUE
At 31 January 2024 5,022
At 31 January 2023 1,675

5. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2024 2023
£    £   
Other debtors 3,888 3,033

Heart Aesthetics Ltd (Registered number: 11788302)

Notes to the Financial Statements - continued
for the Year Ended 31 January 2024

6. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2024 2023
£    £   
Bank loans and overdrafts 10,000 10,000
Payments on account 479 4,223
Trade creditors 32,939 27,940
Taxation and social security 54,014 57,950
Other creditors 2,994 2,566
100,426 102,679

Other creditors includes an amount owed to the director.

7. CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE YEAR
2024 2023
£    £   
Bank loans 13,334 23,333

8. PROVISIONS FOR LIABILITIES
2024 2023
£    £   
Deferred tax
Accelerated capital allowances 1,144 403

Deferred
tax
£   
Balance at 1 February 2023 403
Charge to Income Statement during year 741
Balance at 31 January 2024 1,144

9. CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:
Number: Class: Nominal 2024 2023
value: £    £   
100 Ordinary £1 100 100

Heart Aesthetics Ltd (Registered number: 11788302)

Notes to the Financial Statements - continued
for the Year Ended 31 January 2024

10. DIRECTOR'S ADVANCES, CREDITS AND GUARANTEES

The following advances and credits to a director subsisted during the years ended 31 January 2024 and 31 January 2023:

2024 2023
£    £   
R M Johnson
Balance outstanding at start of year - -
Amounts advanced 10,742 8,028
Amounts repaid (10,742 ) (8,028 )
Amounts written off - -
Amounts waived - -
Balance outstanding at end of year - -